Duodenal mucosal barrier

The duodenal mucosal barrier is a sophisticated multi-component system that protects the duodenum from the corrosive effects of gastric acid and proteolytic enzymes like pepsin. It is structurally organized into three layers: the pre-epithelial layer consisting of mucus and bicarbonate, the epithelial layer comprising tight junctions and cell membranes, and the post-epithelial layer involving blood flow and acid-base regulation (Source: PMID: 24639805). This barrier is essential for maintaining intestinal integrity and preventing the development of ulcers and inflammation. In clinical practice, this system is addressed by cytoprotective drugs that either reinforce the physical barrier or stimulate endogenous protective mechanisms, such as prostaglandin synthesis (Source: StatPearls, Peptic Ulcer Disease). Dysfunction of this barrier is a hallmark of peptic ulcer disease and is often exacerbated by factors like H. pylori infection or NSAID use. Therapeutic strategies focusing on the duodenal mucosal barrier aim to restore the balance between aggressive factors and defensive mechanisms to promote healing and prevent recurrence. Key drugs interacting with this barrier include Misoprostol, which mimics protective prostaglandins, and Sucralfate, which forms a physical shield over damaged areas (Source: PubChem). Monitoring the integrity of this barrier often involves measuring transepithelial electrical resistance or using permeability markers like zonulin (Source: NIH).

Other names

Duodenal mucosal liningDuodenal barrierIntestinal mucosal barrierGastroduodenal mucosal barrier

Stimulation of prostaglandin E1 receptors, physical coating of ulcerated tissue, enhancement of bicarbonate and mucus secretion, and stabilization of the mucosal microcirculation (Source: StatPearls).